Pfizer - before the bell

[fenders53]

(02-08-2022, 09:49 AM)Scooterd Wrote:

(02-08-2022, 09:32 AM)stockguru Wrote: PFE is too dependent on Covid. That's what the street sees them as. And as Covid numbers come down they wont be able to repeat those numbers.

I will be jumping on their 10am call.

Phama is all about Pipeline and growth,
And Pfizer has a very Robust pipeline in and of itself (regardless of partnerships and future Bolt on Acquisitions) -

At Present

• 27 new drugs in Phase 1 trials
  
• 25 new drugs in Phase 2 trials
  
• 27 new drugs in Phase 3 trials
  
• 10 Registration
  
• 89Total
  

You can download their Pipeline here  - https://www.pfizer.com/science/drug-product-pipeline

Their present product list here (too many to count)  - https://www.pfizer.com/products/product-list

- Scoot

Guru is right about market sentiment.  Half of pharma has this problem even though they grow and pay a decent dividend.  I've owned PFE for 26ish years and they habitually attract a lower multiple then they deserve.  They should have a ton of cash now so I am not afraid to own it in reasonable quantities.  I bought a bunch before the Covid runup but sold that.  Still have my long held shares.